As a member of the Organizing Committee Member (OCM) of the International Conference on Psychology,
Autism and Alzheimer’s Disease at San Antonio, Texas, USA from September 30 to October 1, 2013, it
is my pleasure to welcome you to this important event.
We expect that this decade will see great advances in neurosciences. My own work in the area of
the effects of neurohormones on the brain shows the potential for great strides in this field. Thus, i
would like to make a few remarks on one of the important stream topics of the conference, Alzheimer’s
Alzheimer’s disease is the most common cause of age-related dementia in the elderly, characterized by
memory loss and cognitive decline. Alzheimer’s disease degrades the quality of life of patients, puts
a major burden on the family and the caregivers, costs nations around the world billions of dollars
annually and has a dismal outcome. Because the people are living longer the number of individuals
afflicted with Alzheimer’s disease is continuing to climb, creating a major global health problem. We
must find new ways to treat this devastating disease.
Therefore, it is very useful to bring together experts from the field of neurology and psychology for
discussions of the latest advances and ideas, and to stimulate interdisciplinary interactions.
Conferences like this one may help to speed up the development of effective therapies for
neurodegenerative diseases like Alzheimer’s and for autism and other psychological disorders.
Once again i am delighted to invite you to take part in this conference.
Regards Andrew V. Schally Nobel Prize in Physiology/Medicine for 1977
Joseph M. Rifkind
National Institute of Health